NPR News·4 min read·medium
Peptides get their regulatory closeup
W
Will Stone
✦AI Summary
The FDA is convening an expert panel to evaluate whether compounding pharmacies should be permitted to produce popular injectable peptides. While wellness proponents argue for increased access, experts warn that these substances lack rigorous safety and efficacy testing.
Stay up to date with our Up First newsletter, sent every weekday morning.
healthbusiness
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in